−0.18CNY
−76.07 MCNY
405.41 MCNY
419.38 M
About JIANGSU AIDEA PHARMACEUTICAL
Sector
CEO
Jie Zhang
Headquarters
Yangzhou
Website
Employees (FY)
476
Founded
2009
ISIN
CNE1000041S6
FIGI
BBG00QK5KZ99
Jiangsu Aidea Pharmaceutical Co., Ltd. produces and sells human protein products, and carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents. The company operates through two segments: Formulated Products and Raw Materials. Its products include Folium Sennae Granules, Powdered Bacillus Tablets, Clindamycin Hydrochloride Capsules, Sodium Bicarbonate Tablets, Nitrendipine Tablets, Metronidazole Tablets, Compound Gentamycin Sulfate and Procaine Hydrochloride Sulfate Granules, Cefradine Capsules, Human Urinary Kallidinogenase, Crude Ulinastatin & Urokinase, High Purity Urokinase, Human Serum Albumin, Epidermal Growth Factor, Crude Human Epidermal Growth Factor, Beta-2 Microglobulin and Crude Beta-2 Microglobulin. Jiangsu Aidea Pharmaceutical was founded on December 15, 2009 and is headquartered in Yangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688488 is 15.63 CNY — it has increased by 2.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGSU AIDEA PHARMACEUTICAL stocks are traded under the ticker 688488.
688488 stock is 6.78% volatile and has beta coefficient of 1.11. Check out the list of the most volatile stocks — is JIANGSU AIDEA PHARMACEUTICAL there?
Yes, you can track JIANGSU AIDEA PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
688488 stock has risen by 3.10% compared to the previous week, the month change is a 0.77% rise, over the last year JIANGSU AIDEA PHARMACEUTICAL has showed a 3.78% increase.
688488 net income for the last quarter is −43.61 M CNY, while the quarter before that showed −22.86 M CNY of net income which accounts for −90.79% change. Track more JIANGSU AIDEA PHARMACEUTICAL financial stats to get the full picture.
Today JIANGSU AIDEA PHARMACEUTICAL has the market capitalization of 6.44 B, it has increased by 2.04% over the last week.
Like other stocks, 688488 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU AIDEA PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 476.00 employees. See our rating of the largest employees — is JIANGSU AIDEA PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGSU AIDEA PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGSU AIDEA PHARMACEUTICAL stock shows the strong buy signal. See more of JIANGSU AIDEA PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JIANGSU AIDEA PHARMACEUTICAL EBITDA is −58.44 M CNY, and current EBITDA margin is −14.37%. See more stats in JIANGSU AIDEA PHARMACEUTICAL financial statements.